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INTRODUCTION:  Several  conventional  techniques  have  been  developed  in  order to  control  surgical  bleed-
ing.  Their  greatest  disadvantage,  though,  is  their  inability  to control  bleeding  in  areas  where  access  is
very  difﬁcult.  In  such  cases  the  application  of topical  hemostatic  agents  may  prove  particularly  useful.
PRESENTATION OF  CASE:  We  describe  the case  of  an  82-year  old  patient  with  life-threatening  post-
ERCP  bleeding  which  was  intraoperatively  controlled  with  infusion  of a topical  gelatin  matrix-thrombin
hemostatic  agent  into  the distal  portion  of  the  common  bile  duct.
DISCUSSION: Most  iatrogenic  cases  of  post-ERCP  bleeding  occur  at the  site  of  sphincterotomy  at the  level
of  the  ampulla  of Vater  and may  be relatively  easily  controlled  by  repeat  endoscopy  and  local  hemo-elatin  matrix-thrombin
opical hemostatic agent
static  measures.  More  rarely,  however,  signiﬁcant  and  difﬁcult  to  control  bleeding  may  occur  within  the
lower  portion  of  the  common  bile  duct  (CBD)  where  routine  hemostatic  techniques  may  prove  unsuccess-
ful.  Under  these  circumstances,  we  successfully  employed  a  novel  hemostatic  technique  using  a  gelatin
matrix-thrombin  agent  in a patient  with  life-threatening  bleeding  after  ERCP.
CONCLUSION: This  novel  technique  might  prove  particularly  useful  for bleeding  control  in surgically
challenging  anatomical  areas  such  as the  lower  portion  of the  CBD.
ical A© 2012 Surg
. Introduction
Several conventional techniques have been developed in order
o control surgical bleeding including mechanical means (manual
ompression, ligation, use of tourniquet) or sealing of bleeding ves-
els by thermal methods (laser or electrocauterization). All these
echniques may  prolong operative time or produce necrotic areas
ith increased likelihood of infection and impaired healing.1,2 Their
reatest disadvantage though is their inability to control bleeding
n areas where access by the surgeon is very difﬁcult and/or might
ndanger vital structures. In such cases the application of topi-
al hemostatic agents may  prove particularly useful. Several types
f hemostatic agents are currently available exerting their hemo-
tatic effect in a variety of ways. Some of them promote primary
emostasis whereas others stimulate ﬁbrin formation or imple-
ent a biocompatible matrix in order to achieve their effect.3
Endoscopic retrograde cholangiopancreatography (ERCP) is a
echnically complex endoscopic procedure that may, under certain
ircumstances, bear signiﬁcant morbidity and occasional mortal-
ty. In three recent large prospective multicenter studies the rate of
evere or fatal complications ranged between 2.1 and 4%.4–6 Severe
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post-ERCP hemorrhage is a rare fatal complication with a reported
prevalence of about 0.2%.7,8 Surgical control of this complication
may prove particularly difﬁcult due to problematic access of the
bleeding area. In this article we report the case of an 82-year old
woman with a life threatening post-ERCP bleeding which was con-
trolled intraoperatively with the application of a topical hemostatic
agent in the distal portion of the common bile duct (CBD).
2.  Presentation of case
An 82-year old woman  was  admitted to our hospital due to
severe acute cholecystitis, which was  clinically suspected and
sonographically conﬁrmed. Initial treatment included a NPO regi-
men, correction of ﬂuid and electrolytes and intravenous antibiotic
therapy (tazobactam/piperacillin and metronidazole). Past medical
and surgical history were remarkable of pharmacologically con-
trolled arterial hypertension and an open partial gastrectomy due
to bleeding gastric ulcer, respectively. On day 3 after admission
a laborious open cholecystectomy was performed. Intraoperative
ﬁndings were necrotic gangrenous cholecystitis and secondary rup-
ture of the gallbladder with subhepatic abscess formation. On the
third postoperative day the patient had ongoing bile leak at the
Open access under CC BY-NC-ND license.subhepatic drain (500 mL/day), thus an ERCP was conducted. At
ERCP, bile leak was recognized through the stump of the cystic duct;
a temporary plastic stent was placed in the CBD and adjunctive
sphincterotomy was  performed.
BY-NC-ND license.
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Fig. 1. (a–d) Operative steps of post-ERCP bleeding control in our patient. (a) A longitudinal incision was made at the second part of the duodenum (Dd) providing excellent
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c)  cannulation of the ampulla with a Nelaton catheter (Nel) prevents occlusion of 
d)  the gelatin matrix-thrombin hemostatic has been infused in the distal part of th
Twelve hours post-ERCP the patient developed severe upper
astrointestinal bleeding associated with blood loss per rectum and
emodynamic instability. After initial resuscitation we performed
 new ERCP in order to deﬁne the site of bleeding and attempt
ndoscopic control. The site of sphincterotomy was  identiﬁed as
he source of active arterial bleeding, however the endoscopist’s
ttempts for local control were unsuccessful. Subsequently an
rgent selective arteriography was performed in the operating
oom, where the source of bleeding was shown to be a branch
f the gastroduodenal artery (GDA), which was embolized with
oil material. The patient suffered continuous bleeding even after
he embolization of the main trunk of GDA and, due to progres-
ive hemodynamic instability, an urgent surgical exploration was
onsidered an imperative option.
An attempt to ligate the GDA was not made at surgical explo-
ation for two reasons. First, dissection of the arterial structures
ust above the duodenum would be very dangerous and could
ead to inadvertent damage to the main hepatic arterial trunks
nd/or the supraduodenal part of the CBD. The timing of emer-
ency operation, i.e. 6 days from initial presentation, and the extent
f local inﬂammation due to previous gallbladder rupture were
nfavorable factors for a safe dissection and ligation of the GDA.
econd, at arteriography, selective coil embolization of a branch
nd the main trunk of GD artery, although technically successful,
as unable to control bleeding. Thus, we performed a longitudinal
uodenotomy which provided adequate exposure of the ampulla
f Vater and the sphincter of Oddi (Fig. 1a). Arterial bleeding at
he site of sphincterotomy was initially encountered after removal
f fresh, non-adherent blood clots from the duodenal lumen. Flexi-
le choledochoscopy also conﬁrmed active intraluminal bleeding at
he distal part of the CBD (Fig. 1b). We  attempted bleeding control
ith conventional means by both suturing the site of sphinctero-
omy and exerting internal pressure on the bleeding vessels of theith a choledochoscope (Ch); active bleeding through the cannulation site is visible,
D during infusion of the topical hemostatic agent (FS, FloSeal infusion device) and
 (arrowheads), resulting in successful bleeding control.
distal CBD with balloon tipped catheters. Nevertheless, bleeding
was not controlled by these conventional means, so we  decided
to innovate. We  infused a topical hemostatic agent consisting
of a bovine-derived gelatin matrix and a human-derived throm-
bin component (FloSeal Hemostatic Matrix, Baxter International
Inc.) into the distal portion of the CBD through the sphincter of
Oddi. In order to keep the lumen open, we cannulated the CBD
with a short piece of a Nelaton catheter (0.3 Fr) (Fig. 1c and d).
This technique achieved complete hemostasis three minutes later.
Then we  removed the short piece of Nelaton catheter very care-
fully and we  performed closure of the duodenotomy according
to the Heineke–Mikulicz technique. Postoperatively, the patient
remained stable at the ICU with no signs of gastrointestinal bleed-
ing for the next twenty days, although she ﬁnally passed away due
to pulmonary complications. During the postoperative period, we
noticed only a mild increase in bilirubin (up to 3.8 mg/dL), alkaline
phosphatase (up to 280 IU/L) and alanine aminotransferase (up to
110 IU/L) levels, which returned to normal within four days. This
was attributed to a temporary obstruction of the CBD by both severe
local inﬂammation and the topical hemostatic agent.
3.  Discussion
As conventional means of hemostasis seem not to be always
effective in controlling bleeding from complex injuries where
access to the site of bleeding is difﬁcult, the application of topical
hemostatic agents might be particularly useful in such situations.3
Several types of hemostatic agents are currently available with
diverse modes of function. Floseal® consists of a bovine-derived
gelatin matrix component and a human-derived thrombin com-
ponent. The mechanism of action of gelatin-based hemostatic
agents is not completely understood. FloSeal matrix works through
a combination of mechanical and pharmacological effects. The
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ranules in the gel swell by 10–20% when contact with blood or
ody ﬂuid occurs, so that blood ﬂow is reduced by a local tam-
onade effect. Additionally, the thrombin component reinforces
emostasis through a pharmacological pathway. The double action
f this product renders it appropriate for local control of heavy
leeding.9–11
Several studies have been published in the pertinent literature
egarding the effectiveness of FloSeal in conditions requiring bleed-
ng control. It has been used in open and laparoscopic urological
rocedures, in liver trauma, in neurosurgery both in experimen-
al studies and clinical cases.12–15 The most important application
f this topical hemostatic agent is probably a number of ear, nose
nd throat procedures, where access to a bleeding site at these
natomical areas may  be extremely difﬁcult.16 In our case we  took
dvantage of this speciﬁc feature of the product, i.e. its effective-
ess in areas with difﬁcult access. As bleeding from the lower part
f the CBD could not be otherwise controlled, we used the special
evice included for the local application of the hemostatic with spe-
ial care not to occlude the lumen of the CBD. This novel technique
f intraluminal bleeding control has not been previously described
or the surgically challenging area of CBD and sphincter of Oddi.
The  application of a topical hemostatic agent onto the epithe-
ium of the CBD was  not associated with any short-term
omplications in our patient. However, safety of these agents
emains a crucial issue as the extent of tissue reaction against
hem has not been fully elucidated. When implanted subdurally in
abbit model these agents appeared safe, although transient gran-
lomatous inﬂammation of variable severity was described. Some
f the reported mild adverse effects of gelatin-based hemostatic
gents include foreign-body reactions, excessive ﬁbrosis, fever
nd failure of absorption. Multiple neurological events have been
escribed when used in laminectomies, such as spinal stenosis,
eningitis, headaches, paresthesias, pain and bladder and bowel
ysfunction.17 The long-term effects of FloSeal on CBD epithelium
annot be accurately predicted.
.  Conclusion
The application of topical hemostatic agents is a very useful tool
or the quick and safe control of bleeding, especially in areas where
urgical access is difﬁcult and the conventional hemostatic means
re only inadequately effective. Life-threatening bleeding arising in
he CBD obviously belongs to these situations. Nevertheless, further
tudies are required both in the direction of safety documentation
f these products and improvement of infusion devices as well as
he effectiveness of their components.
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